Promega Hosts Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) Program
MADISON, Wis.--(BUSINESS WIRE)--Oct 11, 2019--
Promega Corporation this week is hosting a hands-on research academy for colorectal cancer survivors, caregivers and other members of the Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) program. RATS advocates are volunteers from around the country who train to gain a comprehensive understanding of basic science, as well as clinical and diagnostic research in colorectal cancer and related diseases, so they can be empowered to work for the advancement of cancer research in new and innovative ways.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191011005534/en/
Colorectal cancer survivors, caregivers and other members of the Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) program spent time in Promega labs this week for a hands-on research academy hosted by Promega Corporation. RATS advocates train to gain a comprehensive understanding of key issues impacting colorectal cancer research. Above, participants engage in a lesson about genetic transformation of bacteria with luciferase. (Photo: Business Wire)
During the two-day interactive training event on the Promega Madison campus, participants will have the unique opportunity to engage in lab activities with Promega scientists while learning about topics such as:
Special guest Stacy Hurt, an accomplished executive in the healthcare industry, will also share lessons she learned while overcoming stage IV colorectal cancer.
“We’re excited about this opportunity to work alongside advocates for colorectal cancer research in our Promega labs to offer them an up-close, hands-on perspective of the research process and learn from each of their particular experiences as well,” says Heather Tomlinson, Director of Clinical Diagnostics at Promega “We are especially eager to share our insight of the role inherited genetic conditions such as Lynch syndrome plays in increasing the likelihood of developing colorectal and other types of cancer, and how simple screening tests performed on cancerous tumor tissue can determine if Lynch syndrome is likely.”
This is the first Fight CRC RATS research academy Promega has hosted and is a continuation of the company’s commitment, announced in March for Colorectal Cancer Awareness month and National Lynch Syndrome Awareness Day (March 22), to advance colorectal cancer education.
Learn more about Promega support of colorectal cancer research at www.Promega.com/FightCRC.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 4,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.Promega.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191011005534/en/
CONTACT: Contact: Penny Patterson
Phone: (608) 274-4330
KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN
INDUSTRY KEYWORD: OTHER HEALTH MEN RESEARCH RADIOLOGY PHARMACEUTICAL FAMILY ONCOLOGY CONSUMER HOSPITALS GENETICS CLINICAL TRIALS BIOTECHNOLOGY HEALTH SCIENCE NURSING STEM CELLS FDA GENERAL HEALTH PHILANTHROPY OTHER EDUCATION EDUCATION PARENTING OTHER CONSUMER CHILDREN WOMEN SENIORS OTHER PHILANTHROPY OTHER SCIENCE
SOURCE: Promega Corporation
Copyright Business Wire 2019.
PUB: 10/11/2019 03:40 PM/DISC: 10/11/2019 03:41 PM